Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Notable: Adventitial Histopathology in Borderline Ascending Aortic Dilatatio Study completion date changed from estimate of Sep 1, 2025 to Jun 30, 2026 Samsun UniversityNot specified NCT07034586
  2. Notable: Butyrate Effect on Diarrhea Primary completion date changed from estimate of Dec 31, 2025 to Oct 30, 2026 University of PadovaNot applicable NCT06982703
  3. Notable: Lokomat-Robot Assisted Gait Training on Gross Motor Function in Children and Young · Cerebral Palsy Start date pushed from Aug 31, 2026 to Jan 31, 2027 Semmelweis UniversityNot applicable NCT07732205
  4. Notable: TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention Primary completion moved earlier from Feb 17, 2040 to Oct 2036 University Medical Center NijmegenNot applicable NCT04294927
  5. Notable: Virtual Outreach and Individualized Coaching Extension Start date pushed from Oct 2026 to Dec 2026 Emory UniversityNot applicable NCT07836114
  6. Notable: Understanding How Peer Support Helps in Mental Health Care Start date pushed from Sep 2026 to Nov 2026 University of BordeauxNot specified NCT07849621
  7. Notable: Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation Start date pushed from Jan 15, 2027 to Mar 15, 2027 Johns Hopkins UniversityNot applicable NCT06989970
  8. Notable: Forging New Paths: Building Interventions · Criminogenic Needs in Community Based Mental Health Settings Results posted: Nov 18, 2026 University of North Carolina, Chapel HillNot applicable NCT06290648
  9. Notable: Nectin-4 Specific LMW PET Probe Imaging in Multiple Solid Tumors Enrollment increased: 20 → 40 participants Peking University Cancer Hospital & InstituteNot applicable NCT05321316
  10. Notable: AI-enabled Communication to Advance Research Engagement (AI-CARE) Start date pushed from Oct 1, 2026 to Jan 15, 2027 Albert Einstein College of MedicineNot applicable NCT07788898
  11. Notable: MyStroke for Stroke Survivors and Caregivers Start date pushed from Nov 1, 2026 to Dec 1, 2026 University of PennsylvaniaNot applicable NCT06442631
  12. Notable: Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum Primary completion date changed from estimate of May 30, 2025 to Dec 31, 2025 University of TorontoNot specified NCT06744491
  13. Notable: Culturally Adapted Motivational Interviewing With CBT and Mindfulness Based Relapse Prevention for Substance Use Disorder in Pakistan (CAMIAB) Primary completion date changed from estimate of Jun 2025 to Jun 20, 2026 Pakistan Institute of Living and LearningNot applicable NCT04885569
  14. Notable: Collection of Venous and Capillary Blood Samples Research, Optimization and Calibration of New Diagnostic Devices Enrollment reduced: 30000 → 12000 participants LumiraDx UK LimitedNot specified NCT07378514
  15. Notable: PDS Versus NACT-IDS in AI-Selected Advanced Epithelial Ovarian Cancer Enrollment reduced: 534 → 130 participants Shanghai Gynecologic Oncology GroupPhase 2 NCT07931313
  16. Notable: Opioid-Free Anesthesia in Colorectal Surgery, 2025 (OFA-CRC-2025) Enrollment reduced: 200 → 100 participants Hospital Universitario La FePhase 1/2 NCT07771049
  17. Notable: Intravenous Versus Oral Treatment of the Main Acute Infections Enrollment reduced: 4000 → 2640 participants University of Southern DenmarkNot applicable NCT06715306
  18. Notable: Community Study to Increase Mammogram Screening Among Overdue Women Enrollment reduced: 15000 → 1500 participants National University Hospital, SingaporeNot applicable NCT07832396
  19. Notable: Intensive Weight Loss Intervention Versus Bariatric Surgery · Severe and Complex Obesity: the LightBAR Randomised Trial Enrollment reduced: 500 → 316 participants Carsten DirksenNot applicable NCT06309238
  20. Notable: Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study Enrollment reduced: 400 → 240 participants Cairo UniversityNot specified NCT07294313
  21. Notable: 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream · Lichen Sclerosus Primary endpoint(s) modified LEO PharmaPhase 3 NCT07335588
  22. Notable: Garetosmab Versus Placebo Administered Intravenously (IV) · Fibrodysplasia Ossificans Progressiva (FOP) Results posted: Nov 17, 2026 Regeneron PharmaceuticalsPhase 3 NCT05394116
  23. Notable: Orally Administered JBI-802 · Essential Thrombocythemia (ET) and Polycythemia Vera (PV) With Thrombocytosis Primary and study completion dates pushed to Jan 30, 2031 Jubilant Therapeutics Inc.Phase 1/2 NCT07612280
  24. Notable: Trials of SHR-8203 Injection · Advanced Solid Tumors Recruitment opened Beijing Suncadia Pharmaceuticals Co., LtdPhase 1/2 NCT07769242
  25. Notable: HER3-DXd · Locally Advanced or Metastatic Solid Tumors Primary completion pushed from Sep 1, 2027 to Nov 19, 2030 Daiichi SankyoPhase 2 NCT06172478